Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Minocycline to Treat Amyotrophic Lateral Sclerosis

ClinicalTrials.gov ID: NCT00047723

Public ClinicalTrials.gov record NCT00047723. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 19, 2026, 2:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to test the safety, tolerability, and effectiveness of minocycline compared to placebo in patients with amyotrophic lateral sclerosis (ALS).

Study identification

NCT ID
NCT00047723
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
400 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
21 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2002
Primary completion
Not listed
Completion
Dec 31, 2006
Last update posted
Dec 20, 2007

2003 – 2007

United States locations

U.S. sites
30
U.S. states
22
U.S. cities
28
Facility City State ZIP Site status
Mayo Clinic Scottsdale Arizona
University of California, Irvine Irvine California
University of California Department of Neurology Los Angeles California
California Pacific Medical Center San Francisco California
Univ. of Colorado Health Sciences Center Denver Colorado
Mayo Clinic Jacksonville Florida
University of Illinois Chicago Illinois
Indiana University School of Medicine Indianapolis Indiana
University of Iowa Iowa City Iowa
University of Kansas Medical Center Kansas City Kansas
University of Kentucky Lexington Kentucky
Hennepin County Med Center Minneapolis Minnesota
University of Minnesota Minneapolis Minnesota
Washington University St Louis Missouri
UMDNJ/Robert Wood Johnson Medical Center New Brunswick New Jersey
University of New Mexico Albuquerque New Mexico
Columbia Unversity, Eleanor and Lou Gehrig MDA/ALS Center New York New York 10032
Carolinas Medical Center Charlotte North Carolina
Duke University Durham North Carolina
Wake Forest University Winston-Salem North Carolina
Metro Health Clinic Cleveland Ohio
Oregon Health & Science University Portland Oregon
University of Pennsylvania Philadelphia Pennsylvania 19104
Drexel University College of Medicine, Hahnemann Campus Philadelphia Pennsylvania
University of Texas Southwestern Dallas Texas
Methodist Hospital Houston Texas
University of Texas Health Sciences Center San Antonio Texas
University of Utah Salt Lake City Utah
University of Vermont Burlington Vermont
Virginia Mason Medical Center Seattle Washington

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00047723, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2007 · Synced Sep 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00047723 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →